Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

Background & Aims The paradigm for treatment for ulcerative colitis (UC) is shifting from
resolving symptoms toward objective measures such as mucosal healing (MH). However, it …

Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic
inflammation extending to a variable extent from the rectum. Care of the patient with UC …

This is the second of a series of two articles reporting the European Crohn's and Colitis
Organisation [ECCO] evidence-based consensus on the management of adult patients with …

Importance The clinical effects of risankizumab (a monoclonal antibody that selectively
targets the p19 subunit of IL-23) for the treatment of ulcerative colitis are unknown. Objective …

Endoscopy plays an essential role in the diagnosis, management, prognosis, and
surveillance of inflammatory bowel disease (IBD), but surprisingly there are few available …

Background & Aims Subcutaneous golimumab, a fully human monoclonal antibody to tumor
necrosis factor-α (TNFα), was evaluated as maintenance therapy in TNFα antagonist-naive …

Guidelines for clinical practice are aimed to indicate preferred approaches to medical
problems as established by scientifically valid research. Double-blind placebo controlled …

Background One-third of patients with acute severe ulcerative colitis [ASUC] are steroid-
refractory. We aimed to review the different options for the management of steroid-refractory …

Background: The prognosis of acute severe ulcerative colitis (ASC) influences therapeutic
decisions, but data on prevalence or long-term outcome are few. Methods: A systematic …